Log in to access your PharmaMiles
and download the data
| Last Updated on PharmaCompass | Virtual Booth | Country | Labeler | NDC Package Code | Non Proprietary Name | Start Marketing Date | End Marketing Date | Category Code | Dosage Form (Strength) |
|---|---|---|---|---|---|---|---|---|---|
| 31/10/2025 | BSP Pharmaceuticals S.p.A. | 43624-004 | Loncastuximab tesirine | 2021-05-01 | 2026-12-31 | DRUG FOR FURTHER PROCESSING | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (10mg/2.2mL) |
